ARTG 321669Cryogenic spray, cutaneous
ARTG ID: 321669 · Arrotex Pharmaceuticals Pty Ltd · Oystershell NV · Class IIa · Started August 12, 2019
Good Name: Arrotex Pharmaceuticals Pty Ltd - Cryogenic spray, cutaneous
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 321669
- Start Date
- August 12, 2019
- Effective Date
- August 12, 2019
- Name
- Oystershell NV
- Country
- Belgium
- Address
- Nijverheidsweg 10, Merelbeke, 9820
A device used to treat warts and verrucas by freezing.
Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 321669 and sponsored by Arrotex Pharmaceuticals Pty Ltd, manufactured by Oystershell NV in Belgium. The device registration started on August 12, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.